WVE
Wave Life Sciences LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.23B
P/E Ratio
—
EPS
$-1.05
Beta
-1.32
52W High
$21.73
52W Low
$5.02
50-Day MA
$7.95
200-Day MA
$10.09
Dividend Yield
—
Profit Margin
-255.70%
Forward P/E
—
PEG Ratio
0.00
About Wave Life Sciences Ltd
Wave Life Sciences Ltd., a clinical-stage genetic medicine company, designs, optimizes and produces new stereopure oligonucleotides through PRISM, a drug discovery and development platform. The company is headquartered in Singapore.
Fundamentals
| Revenue (TTM) | $71.80M |
| Gross Profit (TTM) | $-117.80M |
| EBITDA | $-193.47M |
| Operating Margin | -81.80% |
| Return on Equity | -53.10% |
| Return on Assets | -28.20% |
| Revenue/Share (TTM) | $0.40 |
| Book Value | $2.76 |
| Price-to-Book | 2.40 |
| Price-to-Sales (TTM) | 17.10 |
| EV/Revenue | 9.73 |
| EV/EBITDA | -10.12 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 316.90% |
| Shares Outstanding | $192.40M |
| Float | $90.11M |
| % Insiders | 15.88% |
| % Institutions | 82.33% |
Analyst Ratings
Consensus ($21.94 target)
2
Strong Buy14
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026